Prellis Biologics

Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation.

Prellis Biologics is a business in biopharma based in Silicon Valley, California, founded in 2016.

Profile

Prellis is leveraging their unique approach to tissue engineering to support the first use of synthetic human tissue for de novo therapeutic antibody discovery. The company’s platform allows for 3-5x more rapid development of highly specific antibodies with high affinity, generating dozens of diverse candidates for each target, at a cost to the company of an order of magnitude cheaper than prior methods.

Within the biopharma space, the company focuses on its core offering rather than a broad product line.

The company is recorded as being based in Silicon Valley, California.

Its current recorded stage is SOSV portfolio company.

Its team size is recorded as 11-50 employees.

Website: prellisbio.com